Literature DB >> 21398373

Effects of omalizumab in Aspergillus-associated airway disease.

L A Pérez-de-Llano, M C Vennera, A Parra, J Guallar, M Marin, O Asensio, P Ausin, L Borderías, C Fernández, C Granel, A Pérez-Pimiento, M Rubio.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21398373     DOI: 10.1136/thx.2010.153312

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  7 in total

Review 1.  Off-Label Uses of Omalizumab.

Authors:  David El-Qutob
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

2.  Omalizumab: clinical use for the management of asthma.

Authors:  Neil C Thomson; Rekha Chaudhuri
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2012-06-12

Review 3.  IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.

Authors:  Arnau Navinés-Ferrer; Eva Serrano-Candelas; Gustavo-J Molina-Molina; Margarita Martín
Journal:  J Immunol Res       Date:  2016-12-21       Impact factor: 4.818

4.  Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis.

Authors:  Fernanda Sales da Cunha; Solange Oliveira Rodrigues Valle; José Elabras Filho; Sérgio Duarte Dortas Júnior; Alfeu Tavares França
Journal:  J Bras Pneumol       Date:  2018 Sep-Oct       Impact factor: 2.624

5.  Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab.

Authors:  Jennifer Collins; Gabriele Devos; Golda Hudes; David Rosenstreich
Journal:  J Asthma Allergy       Date:  2012-11-08

6.  Steroid sparing effect of omalizumab in seropositive allergic bronchopulmonary aspergillosis.

Authors:  Keith T Beam; Christopher A Coop
Journal:  Allergy Rhinol (Providence)       Date:  2015-01

Review 7.  Allergic Bronchopulmonary Aspergillosis.

Authors:  Michael C Tracy; Caroline U A Okorie; Elizabeth A Foley; Richard B Moss
Journal:  J Fungi (Basel)       Date:  2016-06-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.